Our bacterial whole genome de novo sequencing platform leverages the power of high-throughput sequencing technology to generate accurate draft or complete genomes for microbial identification and comparative genomic studies. We provide reliable sequencing approaches and confidential bioinformatics analysis to help you gain an insight into functional elements, functional genes, and phylogeny.
With the significant reduction in sequencing costs and the exponential improvement in sequencing efficiency, whole-genome sequencing has substantially propelled research in microbial single-genome genomics. Utilizing whole-genome sequences, it is possible to construct comprehensive genome databases for various species. This serves as an efficient platform for subsequent research into critical questions related to the growth, development, evolution, and origin of the species. Furthermore, these sequences provide essential DNA information for future gene mining and functional validation.
Bacterial genome sequencing can be categorized into de novo sequencing and resequencing. Bacterial whole genome de novo sequencing refers to sequencing a species' genome for which the sequence is unknown or lacks closely related genomic information. This process involves constructing genomic libraries with different insert fragment lengths, followed by sequencing and subsequent assembly using bioinformatics methods. The end result is the acquisition of a complete bacterial genomic sequence map, including predictions of gene functions and annotations.
CD Genomics offers comprehensive bacterial whole genome de novo sequencing using a combination of third-generation PacBio SMRT and nanopore sequencing platforms, alongside second-generation Illumina HiSeq technology. This strategy ensures accurate and complete genome assembly by leveraging long reads from PacBio SMRT for complex regions and high-throughput Illumina sequencing for detailed coverage. Our advanced sequencing workflow provides seamless assembly of bacterial genomes, including plasmid information, without gaps or ambiguous bases, addressing challenges in repetitive and high-GC regions. This approach combines automation with cutting-edge technology to deliver reliable and high-quality genomic data.
Note: The above content includes only a portion of the bioinformatics analysis. For more information or to customize the analysis, please contact us directly.
Our bioinformatics analysis involves five parts: data quality control, de novo assembly, genome assessment, functional annotations, and comparative genomic studies. For more details, please refer to the following table.
Table 1. Our bioinformatics analysis for microbial whole genome de novo sequencing.
Analysis content | Details |
---|---|
Data QC | Removal of low-quality reads and adapter sequences |
De novo assembly | Utilize software such as SOAPdenovo and SOAPdenovo2 to assemble reference-quality complete bacterial/fungal genomes. |
Genome assessment | Detection of repetitive sequence, non-coding RNA, CRISPR, prophage, and genomic island. |
Functional annotations | KEGG, SwissProt, GO, Nr, COG (for general functional annotations) |
PHI (database of pathogen-host interaction) | |
VFDB (database of virulence factors of bacterial pathogens) | |
ARDB (database of antibiotic resistance) | |
CAZy (database of Carbohydrate-Active enZYmes) | |
And other databases... | |
Comparative genomic studies | Detection of variants, conserved genes, and unique genes Construction of phylogenetic trees Gene family studies |
Note: If you wish to obtain more accurate and detailed information regarding sample requirements, please feel free to contact us directly.
Partial results of our bacterial whole genome de novo sequencing service are shown below:
Please feel free to reach out if you have any further inquiries or require additional information.
Integrated Comparative Genomic Analysis and Phenotypic Profiling of Pseudomonas aeruginosa Isolates From Crude Oil
Journal: Frontiers in Microbiology
Impact factor: 4.235
Published: 31 March 2020
Backgrounds
Pseudomonas bacteria can survive in harsh environments like crude oil by producing enzymes and rhamnolipids (RLs) that help degrade alkanes. This study compared three such strains, finding they have flexible genomes and high levels of alkane-degrading enzymes, making them suitable for bioremediation and oil recovery.
Methods
Sample preparation:
Method:
Results
IMP66, IMP67, and IMP68 were isolated from crude oil, and their complete genomes were sequenced. Phylogenetic analysis using ten housekeeping genes confirmed that IMP67 and IMP68 are P. aeruginosa, while IMP66 was also identified as P. aeruginosa. A maximum likelihood tree of 54 Pseudomonas strains and core genome analysis of 90 P. aeruginosa isolates revealed that all three strains clustered together in the same group, indicating they are closely related within the P. aeruginosa species.
Figure 1. Phylogeny of P. aeruginosa population structure.
IMP66, IMP67, and IMP68 have similar genome sizes and GC content, with about 6,100 coding sequences (CDSs) each, which is higher than the well-studied PAO1 strain. Compared to PAO1, most crude oil isolates have larger genomes, potentially aiding their survival. Comparative analysis revealed 592 unique genes in IMP66, IMP67, and IMP68, mostly related to mobile genetic elements and gene functions such as transcription and cell wall biogenesis. Horizontal gene transfer (HGT) appears common in these strains, with conserved regions indicating potential gene acquisition and adaptation advantages, including features linked to alkane degradation.
Figure 2. Whole genome comparison of IMP66, IMP67, IMP68, and PAO1.
Conclusions
P. aeruginosa strains IMP66, IMP67, and IMP68, isolated from crude oil, are highly adaptable, excelling in alkane degradation and rhamnolipid production. They have numerous alkane hydroxylase genes and show signs of horizontal gene transfer, enhancing their survival. Their efficient QS signaling helps balance rhamnolipid production. These traits make them promising for bioremediation and industrial applications, with their CRISPR-Cas system offering potential for genetic engineering.
Reference
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.
Please fill out the form below: ×